Literature DB >> 8809874

Exposure to opiates: behavioral outcomes in preschool and school-age children.

K A Kaltenbach1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8809874

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN： 1046-9516


× No keyword cloud information.
  7 in total

1.  Novel biomarkers to assess in utero effects of maternal opioid use: First steps toward understanding short- and long-term neurodevelopmental sequelae.

Authors:  Laura Goetzl; Tara Thompson-Felix; Nune Darbinian; Nana Merabova; Salim Merali; Carmen Merali; Kathryne Sanserino; Tamara Tatevosian; Bruno Fant; Mathieu E Wimmer
Journal:  Genes Brain Behav       Date:  2019-06-11       Impact factor: 3.449

Review 2.  Children of addicted women.

Authors:  Barry M Lester; Linda L Lagasse
Journal:  J Addict Dis       Date:  2010-04

3.  Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.

Authors:  Annemarie Unger; Erika Jung; Bernadette Winklbaur; Gabriele Fischer
Journal:  J Addict Dis       Date:  2010-04

Review 4.  Methadone and buprenorphine for the management of opioid dependence in pregnancy.

Authors:  Hendrée E Jones; Loretta P Finnegan; Karol Kaltenbach
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

5.  Neonatal abstinence syndrome: Neurobehavior at 6 weeks of age in infants with or without pharmacological treatment for withdrawal.

Authors:  Nicole A Heller; Beth A Logan; Deborah G Morrison; Jonathan A Paul; Mark S Brown; Marie J Hayes
Journal:  Dev Psychobiol       Date:  2017-05-31       Impact factor: 3.038

6.  Pharmacological treatment of neonatal opiate withdrawal: between the devil and the deep blue sea.

Authors:  Anthony Liu; Tracey Björkman; Caroline Stewart; Ralph Nanan
Journal:  Int J Pediatr       Date:  2011-05-23

7.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.